Logo for HLS Therapeutics Inc

HLS Therapeutics Investor Relations Material

Latest events

Logo for HLS Therapeutics Inc

Q3 2024

HLS Therapeutics
Logo for HLS Therapeutics

Q3 2024

7 Nov, 2024
Logo for HLS Therapeutics

Q2 2024

8 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from HLS Therapeutics Inc

Access all reports
HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of prescription medications for the treatment of central nervous system (CNS) and cardiovascular conditions. The company specializes in bringing established medications to market, primarily targeting chronic conditions that require long-term treatment. HLS Therapeutics serves patients and healthcare providers across North America with a portfolio of branded medications. The company is headquartered in Toronto, Canada, and its shares are listed on the TSX.